GE HealthCare Technologies’ (GEHC) “Buy” Rating Reiterated at BTIG Research

BTIG Research restated their buy rating on shares of GE HealthCare Technologies (NASDAQ:GEHC) in a research report report published on Thursday,Benzinga reports. The firm currently has a $91.00 price target on the stock.

Several other analysts have also recently issued reports on GEHC. Barclays increased their target price on GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a research report on Friday, February 6th. Bank of America boosted their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research report on Monday, January 5th. Piper Sandler upped their price objective on GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $98.00 price objective on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Finally, Wall Street Zen upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Trading Down 1.1%

NASDAQ GEHC opened at $69.61 on Thursday. GE HealthCare Technologies has a one year low of $57.65 and a one year high of $89.77. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The company has a market capitalization of $31.72 billion, a price-to-earnings ratio of 15.26, a price-to-earnings-growth ratio of 1.53 and a beta of 1.03. The company’s 50-day simple moving average is $79.22 and its two-hundred day simple moving average is $78.43.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts forecast that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is currently 3.07%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. E Fund Management Hong Kong Co. Ltd. boosted its holdings in GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after acquiring an additional 196 shares in the last quarter. Godsey & Gibb Inc. acquired a new position in shares of GE HealthCare Technologies during the third quarter valued at about $26,000. Laurel Wealth Advisors LLC purchased a new position in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $26,000. Optima Capital LLC purchased a new position in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $27,000. Finally, Godfrey Financial Associates Inc. acquired a new stake in GE HealthCare Technologies in the 4th quarter worth approximately $27,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.